Four pharmaceutical companies have obtained a license to market the Filipino-developed anti-diabetes ampalaya (bitter gourd) tablet and are just awaiting reformulation of the drug before hitting the big market for this degenerative disease.
The government has granted a license to Pascual Laboratories Inc., Herbs and Nature, Herbcare Corp., and the state-run Philippine Institute of Traditional and Alternative Herbal Medicine (PITAHC) for the commercialization of ampalaya tablet, according to Philippine Council for Health Research and Development-Department of Science and Technology (PCHRD-DoST).
The ampalaya tablet, a drug for Type 2 Diabetes Mellitus, was originally developed and clinically-tested under the National Integrated Research Program on Medicinal Plants (NIRPROMP), a multi-agency, multi-disciplinary project coordinated by the PCHRD.
No comments:
Post a Comment